
Overview
The Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile study is the Multiple Myeloma Research Foundation (MMRF)’s landmark personalized medicine initiative. CoMMpass is a longitudinal observation study of around 1000 newly diagnosed myeloma patients receiving various standard approved treatments. The MMRF’s vision is to track the treatment and results for each CoMMpass patient so that someday the information can be used to guide decisions for newly diagnosed patients. CoMMpass checked on patients every 6 months for 8 years, collecting tissue samples, genetic, information, quality of life and various disease and clinical outcomes. The study has produced one of the largest genomic and clinical datasets of a single disease.
Features and programs
Open Data Sponsorship Program
Pricing
This is a publicly available data set. No subscription is required.
How can we make this page better?
Legal
Content disclaimer
Delivery details
AWS Data Exchange (ADX)
AWS Data Exchange is a service that helps AWS easily share and manage data entitlements from other organizations at scale.
Open data resources
Available with or without an AWS account.
- How to use
- To access these resources, reference the Amazon Resource Name (ARN) using the AWS Command Line Interface (CLI). Learn more
- Description
- RNA-Seq Gene Expression Quantification
- Resource type
- S3 bucket
- Amazon Resource Name (ARN)
- arn:aws:s3:::gdc-mmrf-commpass-phs000748-2-open
- AWS region
- us-east-1
- AWS CLI access (No AWS account required)
- aws s3 ls --no-sign-request s3://gdc-mmrf-commpass-phs000748-2-open/
Resources
Vendor resources
Support
Contact
How to cite
CoMMpass from the Multiple Myeloma Research Foundation was accessed on DATE from https://registry.opendata.aws/mmrf-commpass .
License
NIH Genomic Data Sharing Policy: https://gdc.cancer.gov/access-data/data-access-policies